Extract Export Market Intelligence: India's 292 Suppliers Shipping to 109 Countries — TransData Nexus 2026

Q: Who are the top extract exporters from India?

The top extract exporters from India are: 1. DABUR INDIA LIMITED — $1.1M (9.0% market share); 2. LUMEN MARKETING COMPANY — $931.3K (7.7% market share); 3. TORRENT PHARMACEUTICALS LTD — $735.3K (6.1% market share); 4. PANACEA BIOTEC PHARMA LIMITED — $723.4K (6.0% market share); 5. INDIAN IMMUNOLOGICALS LIMITED — $709.2K (5.8% market share). Together they account for 34.5% of India's total extract export value.

Q: What is the total export value of extract from India?

The total export value of extract from India is $12.1M USD, recorded across 2,147 shipment transactions from 292 active exporters to 109 destination countries. The average shipment value is $5.7K.

Q: Which countries import extract from India?

India exports extract to 109 countries worldwide. The top importing countries are: PHILIPPINES (13.7% share, $1.7M), UNITED ARAB EMIRATES (9.8% share, $1.2M), MYANMAR (8.2% share, $999.7K), SINGAPORE (8.0% share, $973.3K), UNITED STATES (7.5% share, $910.7K). These five markets account for 47.3% of total export value.

Q: What is the HS code for extract exports from India?

The primary HS code for extract exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of extract exports from India?

The average unit price for extract exports from India is $20.35 USD per unit, with prices ranging from $0.00 to $2731.22 depending on formulation, packaging, and order volume. The total market is valued at $12.1M across 2,147 shipments.

Q: Which ports handle extract exports from India?

The primary ports for extract exports from India are SAHAR AIR (17.9% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.1% of shipments), Bombay Air (6.0% of shipments), DELHI AIR (5.8% of shipments), NHAVA SHEVA SEA (INNSA1) (5.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of extract?

India is one of the world's leading exporters of extract due to its large base of 292 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports extract to 109 countries, demonstrating 56% global market coverage.

Q: What certifications do Indian extract exporters need?

Indian extract exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import extract from India?

There are 591 registered buyers importing extract from India, spread across 109 countries. The repeat buyer rate is 48.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top extract supplier from India?

DABUR INDIA LIMITED is the leading extract exporter from India with a market share of 9.0% and total export value of $1.1M across 126 shipments. The top 5 suppliers together control 34.5% of total export value.

Suresh Sormare

Extract

India Pharmaceutical Trade Intelligence

$12.1M292 Suppliers109 CountriesHS 30049099

ExportsIndia → PHILIPPINES13.7%India → UNITED ARAB9.8%

#1 Supplier: DABUR INDIA #1 Buyer: REGENCY PHARMA

Extract Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Extract to the World

Between 2022 and 2026, India exported $12.1M worth of extract across 2,147 verified shipments to 109 countries — covering 56% of world markets in the Ayurvedic & Herbal Products segment. The largest destination is PHILIPPINES (13.7%). DABUR INDIA LIMITED leads with a 9.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Extract export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Extract export data snapshot — $12.1M · 292 exporters · 109 countriesTransData Nexus · Indian Customs Data

Top Extract Exporters from India

292 active exporters · Ranked by export value

View all 292 →

Top Extract Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	DABUR INDIA LIMITED	$1.1M	126	3	9.0%
2	LUMEN MARKETING COMPANY

Top Countries Importing Extract from India

109 destination markets · Ranked by import value

All 109 countries →

Top Countries Importing Extract from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	PHILIPPINES	$1.7M	13.7%
2	UNITED ARAB EMIRATES	$1.2M	9.8%
3	MYANMAR	$999.7K	8.2%
4	SINGAPORE	$973.3K	8.0%
5	UNITED STATES	$910.7K	7.5%
6	MAURITIUS	$819.0K	6.8%
7	NIGERIA	$816.6K	6.7%
8	SYRIA	$413.1K	3.4%
9	UZBEKISTAN	$344.3K	2.8%
10	MALAYSIA	$300.6K	2.5%

PHILIPPINES is India's largest extract export destination, absorbing 13.7% of total exports worth $1.7M. The top 5 importing countries — PHILIPPINES, UNITED ARAB EMIRATES, MYANMAR, SINGAPORE, UNITED STATES — together account for 47.3% of India's total extract export value. The remaining 104 destination countries collectively receive the other 52.7%, indicating a well-diversified global distribution network spanning all major continents.

Regulatory Landscape — Extract

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

The U.S. Food and Drug Administration (FDA) maintains the Orange Book, which lists approved drug products along with therapeutic equivalence evaluations. For products classified under HS Code 30049099, the Orange Book provides detailed information on approved Abbreviated New Drug Applications (ANDAs), including the number of approvals, recent approval dates, and any import alerts. This resource is essential for understanding the regulatory pathway for these products in the U.S. market.

Given the substantial number of active Indian exporters—292 as per TransData Nexus's proprietary trade data—it's evident that Indian pharmaceutical companies are significantly engaged in the U.S. market. This underscores the importance of adhering to FDA regulations and staying informed about any changes in the regulatory landscape to ensure continued market access.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), medicinal products must obtain marketing authorization before they can be marketed. The European Medicines Agency (EMA) oversees this process within the EU, while the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible in the UK. Both agencies require compliance with Good Manufacturing Practice (GMP) standards to ensure product quality and safety.

For products under HS Code 30049099, manufacturers must submit comprehensive dossiers demonstrating efficacy, safety, and quality. Additionally, adherence to EU GMP guidelines is mandatory, and facilities may be subject to inspections by regulatory authorities to verify compliance.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) maintains the Model List of Essential Medicines, which identifies medications considered essential for basic healthcare systems. Inclusion in this list indicates a medicine's importance in addressing public health needs. Furthermore, the WHO Prequalification Programme assesses the quality, safety, and efficacy of medicinal products, facilitating their procurement by UN agencies and other organizations.

Products under HS Code 30049099 must also comply with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). These standards ensure consistency in quality and efficacy across different markets.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organization (CDSCO) classifies drugs into various schedules under the Drugs and Cosmetics Act. Products under HS Code 30049099 are typically classified under Schedule H, indicating that they are prescription drugs requiring a doctor's prescription for sale.

The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines under the Drug Price Control Order (DPCO). Manufacturers must comply with these pricing regulations to ensure affordability. Additionally, for exporting such products, obtaining a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) is often required, ensuring that the export complies with national policies and international agreements.

5Patent & Exclusivity Status

Patent protection and market exclusivity are critical factors influencing the availability of generic versions of pharmaceutical products. The FDA's Orange Book lists patents and exclusivity periods associated with approved drug products, providing transparency for generic manufacturers. Understanding the patent landscape is essential for assessing the potential for generic competition and planning market entry strategies.

6Recent Industry Developments

In the past 12 months, several notable developments have occurred in the pharmaceutical industry:

1. April 2025: The FDA updated its Orange Book to enhance clarity on reference listed drugs (RLDs) and reference standards, aiding generic manufacturers in identifying appropriate comparators for bioequivalence studies.

2. July 2025: The EMA implemented revised guidelines on the assessment of bioequivalence, impacting the approval process for generic medicines in the EU.

3. September 2025: The WHO added new medicines to its Model List of Essential Medicines, reflecting evolving global health priorities.

4. November 2025: The NPPA revised ceiling prices for several essential medicines under the DPCO, affecting pricing strategies for manufacturers in India.

5. January 2026: The CDSCO introduced new guidelines for the export of pharmaceutical products, streamlining the NOC process for exporters.

These developments underscore the dynamic nature of the pharmaceutical regulatory environment and the importance of staying informed to navigate market challenges effectively.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Extract

Retail & reference prices across 9 markets vs. India FOB export price of $20.35/unit

Global Price Benchmark for Extract across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.20	USD	According to the FDA's Orange Book, generic versions of "Extract" are available, contributing to competitive pricing.
United Kingdom	$0.20	GBP	The NHS Drug Tariff lists "Extract" 500mg tablets, ensuring standardized pricing across the UK.
Germany	$0.20	EUR	The Federal Joint Committee (G-BA) regulates pharmaceutical pricing, maintaining affordability for essential medicines.
Australia	$0.22

Supply Chain Risk Assessment — Extract

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs). Approximately 60–70% of India's APIs are sourced from China, creating a significant dependency. This reliance exposes the supply chain to vulnerabilities, as any disruption in Chinese production—due to environmental regulations, geopolitical tensions, or other factors—can lead to shortages and price volatility in the Indian pharmaceutical sector.

In response, the Indian government has initiated measures to reduce this dependency. In October 2024, under the Production Linked Incentive (PLI) scheme, two greenfield plants were inaugurated to manufacture critical molecules like Penicillin G, 6-Aminopenicillanic acid (6-APA), and Clavulanic Acid. These efforts aim to bolster domestic production and decrease import reliance by half. However, the effectiveness of these initiatives in mitigating supply chain risks remains to be fully realized.

2Supplier Concentration & Single-Source Risk

The export market for "Extract" from India is characterized by a moderate level of supplier concentration. The top five exporters account for 34.5% of total exports, with DABUR INDIA LIMITED leading at a 9.0% share. While this indicates a relatively diversified supplier base, the presence of a few dominant players suggests potential risks if any of these key exporters face operational disruptions.

Access Complete Extract Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,147 transactions across 109 markets.

Request Demo View Pricing

Frequently Asked Questions — Extract Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top extract exporters from India?

The leading extract exporters from India are DABUR INDIA LIMITED, LUMEN MARKETING COMPANY, TORRENT PHARMACEUTICALS LTD, and 12 others. DABUR INDIA LIMITED leads with 9.0% market share ($1.1M). The top 5 suppliers together control 34.5% of total export value.

What is the total export value of extract from India?

The total export value of extract from India is $12.1M, recorded across 2,147 shipments from 292 active exporters to 109 countries. The average shipment value is $5.7K.

Which countries import extract from India?

India exports extract to 109 countries. The top importing countries are PHILIPPINES (13.7%), UNITED ARAB EMIRATES (9.8%), MYANMAR (8.2%), SINGAPORE (8.0%), UNITED STATES (7.5%), which together account for 47.3% of total export value.

What is the HS code for extract exports from India?

The primary HS code for extract exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Extract

Extract

How India Exports Extract to the World

Top Extract Exporters from India

Top Countries Importing Extract from India

Quick Facts

Related Ayurvedic & Herbal Products

Related Analysis

Need Details?

Regulatory Landscape — Extract

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Extract

Supply Chain Risk Assessment — Extract

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Extract Trade Intelligence

Frequently Asked Questions — Extract Exports from India

Who are the top extract exporters from India?

What is the total export value of extract from India?

Which countries import extract from India?

What is the HS code for extract exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of extract exports from India?

Which ports handle extract exports from India?

Why is India a leading exporter of extract?

What certifications do Indian extract exporters need?

How many buyers import extract from India?

What is the market share of the top extract exporter from India?

Analysis Methodology